Category Archives: BioUtah News
Audio-based Detection of Anxiety and Depression via Vocal Biomarkers
Audio-based Detection of Anxiety and Depression via Vocal Biomarkers
bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
Marcy-l’Étoile (France), September 22nd, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has submitted the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel to U.S. Food and Drug Administration (FDA) for a dual 510(k) clearance and CLIA1-waiver. This panel is already CE-marked (IVDD2).
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in […]
Myriad Genetics Issues 2022 Environmental, Social and Governance Report
SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its second annual Environmental, Social and Governance report, highlighting key efforts that reflect its commitment to conduct operations as a responsible, equitable and sustainable partner in the healthcare industry. “At Myriad, […]
Rep. Moore’s Health Staff Visits Utah Life Sciences Companies
Rep. Moore’s Health Staff Tours Visits Utah Life Sciences Companies
Partnership and innovation help SSM Health secure lower-cost, reliable supply of generic drugs
Civica Rx, a health care utility co-founded by SSM Health, supplies critical medications that patients need.
GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries
rant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools
BioUtah, Life Sciences Innovators Take Stage at Legislature’s Interim Meeting
The Utah Life Sciences Innovation Caucus hosted a lunch for all legislators during the September 18.
NUSANO APPOINTS INDUSTRY EXPERT ALEXANDRE GIBIM AS CHIEF OPERATIONS OFFICER
EXECUTIVE WITH THREE DECADES OF SUCCESSFUL MULTINATIONAL OPERATIONS AND COMMERCIAL EXPERIENCE TO LEAD LAUNCH OF PROPRIETARY RADIOISOTOPE PRODUCTION PLATFORM
BioUtah Participates in American Cancer Society Policy Panel Presentation
Kelvyn Cullimore, BioUtah’s CEO, participated as a panelist.
Merit Medical Launches the Aspira® Evacuated Drainage Bottle
Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating a Phase 2 proof-of-concept study in patients with recurrent Clostridioides difficile infection in 2024.
